U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

A receptor that cannabis latches onto in the brain could be a promising target for future mental health treatments.

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.

They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells ...

Discover how cannabinoid receptor type 1 (CB1) influences resilience to stress and its potential in treating anxiety and ...

More than 1 billion people around the world suffer from chronic pain, which can interfere with quality of life, affect a ...

A research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known ...

This achievement leverages the pain-relieving properties of cannabis without inducing mind-altering side effects. The compound has been tested in mice with some positive results. The study highlights ...

Read the paper: A cryptic pocket in CB1 drives peripheral and functional selectivity Many important drug targets are G-protein-coupled receptors (GPCRs), including those activated by blockbuster ...

They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells throughout the body. Working with collaborators at Stanford University ...